Somatropin (HGH) (36IU)
Technische Spezifikationen
| Reinheit (HPLC) | ≥98% (SDS-PAGE / HPLC) |
| CAS-Nummer | 12629-01-5 |
| Form | White lyophilized powder |
| Lagerung | -20°C |
| Sequenz | 191-AA single-chain polypeptide identical to endogenous human pituitary hGH |
| Molekulargewicht | 22,124 g/mol |
| Salzform | Acetate |
| Löslichkeit | Soluble in sterile water; typically supplied with accompanying diluent |
Somatropin (HGH) (36IU)
EUR-Listenpreis · HU, SK, CZ, PL
- Eurozone (EUR)350,00 EUR
- Ungarn (HU)350,00 EUR≈ 140 000 Ft
- Slowakei (SK)350,00 EUR
- Tschechien (CZ)350,00 EUR≈ 8 750 Kč
- Polen (PL)350,00 EUR≈ 1487,50 zł
Gleicher EUR-Listenpreis für Lieferung nach Ungarn, Slowakei, Tschechien und Polen. Abrechnung in EUR.
HUF/CZK/PLN sind indikativ aus EUR umgerechnet; die Slowakei nutzt EUR. Kurse annähernd. Abrechnung in EUR.
Somatropin (rhGH) 36 IU — größeres Format des rekombinanten hGH für umfangreichere Protokolle der GH/IGF-1-Achse. Nur RUO — ausschließlich für Laborforschung; nicht zum menschlichen Verzehr.
Ausschließlich für Laborforschung.
Nicht für den menschlichen Verzehr, tierärztliche oder diagnostische Zwecke.
From the Peptide Explorer
A 191-amino-acid single-chain polypeptide hormone produced via recombinant DNA technology. Binds the growth hormone receptor (GHR) to trigger JAK2-STAT5 signaling, driving IGF-1 production in the liver and exerting direct anabolic, lipolytic, and metabolic effects across peripheral tissues.
Key Mechanisms
- ›GHR receptor dimerization
- ›JAK2-STAT5 signal transduction
- ›Hepatic IGF-1 induction
- ›Direct lipolysis via hormone-sensitive lipase
- ›Counterregulation of insulin
Primary Research Areas
- ›GH deficiency models
- ›Sarcopenia and aging
- ›Body composition research
- ›Wound healing and post-surgical recovery
- ›Metabolic research
Key Research Findings
- Reduced visceral adiposity and improved lipid profile in GH-deficient adults (Johannsson et al., 1997)
- Increased lean body mass and decreased fat mass in hypopituitary cohorts (Cuneo et al., 1991)
- Restored IGF-1 to youthful levels in aged subjects (Rudman et al., NEJM 1990)
Research Overview
A 191-amino-acid single-chain polypeptide hormone produced via recombinant DNA technology. Binds the growth hormone receptor (GHR) to trigger JAK2-STAT5 signaling, driving IGF-1 production in the liver and exerting direct anabolic, lipolytic, and metabolic effects across peripheral tissues.
Origin: Produced by recombinant E. coli expression; sequence identical to pituitary-derived human GH
Mechanism of Action
- GHR receptor dimerization
- JAK2-STAT5 signal transduction
- Hepatic IGF-1 induction
- Direct lipolysis via hormone-sensitive lipase
- Counterregulation of insulin
Primary Research Areas
- GH deficiency models
- Sarcopenia and aging
- Body composition research
- Wound healing and post-surgical recovery
- Metabolic research
Key Published Findings
- Reduced visceral adiposity and improved lipid profile in GH-deficient adults (Johannsson et al., 1997)
- Increased lean body mass and decreased fat mass in hypopituitary cohorts (Cuneo et al., 1991)
- Restored IGF-1 to youthful levels in aged subjects (Rudman et al., NEJM 1990)
Research Protocol
Commonly studied routes: Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
Lyophilized powder stored at 2-8°C. Reconstituted solution 2-8°C, do not freeze
Important Notice
Somatropin (HGH) (36IU) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Forschungsspezifikationen
Synthesized for strict analytical consistency. Verified via HPLC/MS.Qualitätsstandards ansehen →
Handhabung & Lagerung
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in sterile water; typically supplied with accompanying diluent